Cleary Gottlieb is representing Goldman, Sachs & Co. and Morgan Stanley & Co. LLC., as financial advisors to Mead Johnson Nutrition Company in its sale to Reckitt Benckiser Group plc for $90 in cash per share.
The merger, announced February 10, 2017, has an enterprise value of $17.9 billion and is expected to close in the third quarter of 2017 subject to the approval of Mead Johnson and Reckitt Benckiser shareholders, regulatory approvals and other customary closing conditions.
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 110 years. The company’s “Enfa” family of brands, including Enfamil infant formula, is a leading brand franchise in pediatric nutrition.
Reckitt Benckiser is the world’s leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe